Seizure study retracted after authors realize data got “terribly mixed”

ind j pedsA group of neonatologists in Germany has retracted a paper after apparently realizing that their data weren’t what they thought they were.

Here’s the notice, for “Low Dose Lidocaine for Refractory Seizures in Preterm Neonates,” which appeared in the Indian Journal of Pediatrics: Continue reading Seizure study retracted after authors realize data got “terribly mixed”

Authors “regretfully” retract genomics paper for plagiarism

jasbcoverAuthors of a 2012 article in the Journal of Animal Science and Biotechnology have retracted it for plagiarism. 

The article, “Progress of genome wide association study in domestic animals,” came from a group of chicken geneticists in China affiliated with the Ministry of Agriculture in Harbin and Northeast Agricultural University, in the same city.

According to the retraction notice: Continue reading Authors “regretfully” retract genomics paper for plagiarism

Correction for MD Anderson’s Aggarwal, cancer researcher whose work is under investigation

jmm113coverBharat Aggarwal, the highly cited MD Anderson Cancer Center researcher who has confirmed to us that his work is under investigation by the institution, has a correction of his work in the Journal of Molecular Medicine. Troubled images are to blame — as they have been in previous retractions, and at least one other correction, of Aggarwal’s papers.

The paper, “Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor,” was published in December 2010 and cited 15 times since, according to Thomson Scientific’s Web of Knowledge.

Here’s the notice: Continue reading Correction for MD Anderson’s Aggarwal, cancer researcher whose work is under investigation

Hey authors, “Renewable Energy” doesn’t mean you can recycle words

renewableenergycoverRenewable Energy may cover conservation, but that doesn’t mean it expects its authors to recycle their own words. The Elsevier journal is retracting a biodiesel paper it published in February 2012 by a group of Chinese researchers who published much the same work in another title a month later. That periodical, the Journal of the American Oil Chemists Society, from Springer, has retracted its version as well.

Here’s the notice in Renewable Energy: Continue reading Hey authors, “Renewable Energy” doesn’t mean you can recycle words

Do as I say, not as I do? Duplication in ethics journal earns author five-year publishing ban

j business ethicsThe next time a business professor in Thailand is looking for an ethics case study, he might look no further than the mirror.

Mohammad Asif Salam earned himself a five-year ban on publishing in a Springer journal after publishing work there that he’d already published elsewhere. Here’s the notice for “Corporate social responsibility in purchasing and supply chain,” a paper which appeared in the Journal of Business Ethics in 2009: Continue reading Do as I say, not as I do? Duplication in ethics journal earns author five-year publishing ban

RNA paper retracted for “carelessness in including some of the figures”

molcellbiochemHere at Retraction Watch, we’ve covered retractions for misconduct, journal errors, editorial system hacking and even no particular reason.

And that’s just in the last week.

However, we’ve identified a new reported reason: carelessness. A paper in Molecular and Cellular Biochemistry claimed to show how a tiny RNA causes fat cells to die.

Instead, the paper died.

Turned out that rather than describe previously published data, the authors say they inadvertently included a figure that had already appeared in another paper.

The retraction for “miR-598 induces replicative senescence in human adipose tissue-derived mesenchymal stem cells via silent information regulator 1,” reads, in full: Continue reading RNA paper retracted for “carelessness in including some of the figures”

“This publication should be ignored”: Authorship issues, flawed data fell neuro-oncology paper

Neon 2009 regular volume.inddThe Journal of Neuro-Oncology wants you to ignore the following paper: “A single chain (scFv425):sTRAIL fusion protein with specificity for the EGF receptor is effective in vitro but not in an in vivo brain tumor animal model.”

The 2007 article, from a group in The Netherlands, suffered from two fatal problems. According to the retraction notice: Continue reading “This publication should be ignored”: Authorship issues, flawed data fell neuro-oncology paper

Get the lead out: duplication leads to retraction of heavy metal paper

Biological Trace Element Research has retracted a paper by a group of Egyptian authors for duplication.

The paper, “The Effect of Lead Acetate Toxicity on Experimental Male Albino Rat,” came from investigators in the department of Economic Entomology and Pesticides at Cairo University and appeared in December 2011. As the notice states:

Article has been retracted due to duplicate publication.

Here’s the abstract: Continue reading Get the lead out: duplication leads to retraction of heavy metal paper

Giving thanks for plagiarism detection software: Catching up on retractions for the sincerest form of flattery

Today, on Thanksgiving in the U.S., Retraction Watch is taking a bit of a holiday as we dig into some turkey — not to be confused with retractions from Turkey. We’d like to give thanks for the thousands of Retraction Watch readers all over the world who’ve helped us shine a spotlight on the scientific process, warts and all.

And we imagine that journal editors around the globe are giving thanks to plagiarism detection software such as iThenticate, so today’s post is a roundup of some recent retractions for plagiarism: Continue reading Giving thanks for plagiarism detection software: Catching up on retractions for the sincerest form of flattery

Intent was there, but not the intention-to-treat analysis: Breast cancer study retracted

A group of Dutch researchers has retracted a paper they published in March after apparently learning that they’d bungled their statistical analysis in the study.

The article, “Effects of a pre-visit educational website on information recall and needs fulfilment in breast cancer genetic counselling, a randomized controlled trial,” was published in Breast Cancer Research by Akke Albada of the Netherlands Institute for Health Services Research and colleagues.

But according to the notice, Utrecht, we have a problem: Continue reading Intent was there, but not the intention-to-treat analysis: Breast cancer study retracted